About Cabling Installation & Maintenance

Our mission: Bringing practical business and technical intelligence to today's structured cabling professionals

For more than 30 years, Cabling Installation & Maintenance has provided useful, practical information to professionals responsible for the specification, design, installation and management of structured cabling systems serving enterprise, data center and other environments. These professionals are challenged to stay informed of constantly evolving standards, system-design and installation approaches, product and system capabilities, technologies, as well as applications that rely on high-performance structured cabling systems. Our editors synthesize these complex issues into multiple information products. This portfolio of information products provides concrete detail that improves the efficiency of day-to-day operations, and equips cabling professionals with the perspective that enables strategic planning for networks’ optimum long-term performance.

Throughout our annual magazine, weekly email newsletters and 24/7/365 website, Cabling Installation & Maintenance digs into the essential topics our audience focuses on.

  • Design, Installation and Testing: We explain the bottom-up design of cabling systems, from case histories of actual projects to solutions for specific problems or aspects of the design process. We also look at specific installations using a case-history approach to highlight challenging problems, solutions and unique features. Additionally, we examine evolving test-and-measurement technologies and techniques designed to address the standards-governed and practical-use performance requirements of cabling systems.
  • Technology: We evaluate product innovations and technology trends as they impact a particular product class through interviews with manufacturers, installers and users, as well as contributed articles from subject-matter experts.
  • Data Center: Cabling Installation & Maintenance takes an in-depth look at design and installation workmanship issues as well as the unique technology being deployed specifically for data centers.
  • Physical Security: Focusing on the areas in which security and IT—and the infrastructure for both—interlock and overlap, we pay specific attention to Internet Protocol’s influence over the development of security applications.
  • Standards: Tracking the activities of North American and international standards-making organizations, we provide updates on specifications that are in-progress, looking forward to how they will affect cabling-system design and installation. We also produce articles explaining the practical aspects of designing and installing cabling systems in accordance with the specifications of established standards.

Cabling Installation & Maintenance is published by Endeavor Business Media, a division of EndeavorB2B.

Contact Cabling Installation & Maintenance

Editorial

Patrick McLaughlin

Serena Aburahma

Advertising and Sponsorship Sales

Peter Fretty - Vice President, Market Leader

Tim Carli - Business Development Manager

Brayden Hudspeth - Sales Development Representative

Subscriptions and Memberships

Subscribe to our newsletters and manage your subscriptions

Feedback/Problems

Send a message to our general in-box

 

Certara Showcases 2024 Research Wins With Over 100 Papers Published

RADNOR, Pa., Dec. 02, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today showcases its impact on research by celebrating more than 100 publications secured in 2024 as well as the 12 Certara scientists included on the 2024 Stanford/Elsevier list, which highlights the top 2% of the most cited scientists across the globe.

Stanford/Elsevier's Top 2% Scientist Ranking
Now in its 7th iteration, the Stanford/Elsevier's Top 2% Scientist Ranking list includes the top and most-cited researchers globally in 22 scientific disciplines and 174 sub-disciplines and encompasses standardized data on citations, h-index, and a wide range of bibliometric indicators. The following Certara researchers appeared on Elsevier’s top 2% of the world’s most-cited researchers list in 2024, highlighting recent and career-long impacts.

  • Amin Rostami-Hodjegan, Chief Scientific Officer at Simcyp
  • Frederic Bois, Senior Scientific Advisor & Head of Mechanistic Modelling
  • Hannah Jones, Senior Vice President, Head of Simcyp PBPK Modelling Services
  • Hugo Geerts, Head of QSP Neurosciences  
  • Khaled Abduljalil, Senior Principal Scientist at Simcyp
  • Karen Rowland-Yeo, Senior Vice President, Client & Regulatory Strategy
  • Masoud Jamei, Senior Vice President of Research and Development at Simcyp
  • Piet H van der Graaf, Senior Vice President and Head of Quantitative Systems Pharmacology  
  • Patrick Smith, President of Certara Drug Development Solutions   
  • Rajesh Krishna, Distinguished Scientist, Drug Development Science
  • Stephen Duffull, Senior Scientific Advisor
  • Trevor Johnson, Principal Scientist at Simcyp

"Certara is a science-driven organization, and our scientists are world leaders in their fields. Our clients rely on us to deliver advanced biosimulation software and the expert advice needed to interpret results for optimal strategic decision-making,” said William Feehery, CEO, Certara.

2024 Publications
Certara scientists and publications span the entire drug discovery and development process from early discovery through clinical, regulatory, and post-approval. Key highlights and trends evident in 2024 publications are grouped into two primary categories below.

Value and Impact of Biosimulation Strategies and Execution in Drug Development

  • Pediatric oncology drug development and dosage optimization
  • Mechanistic modeling’s impact on first-in-human dose predictions and clinical validations thereof
  • Exposure-Response Analyses to Inform Dosing Considerations and Labeling
  • Impact of physiologically-based pharmacokinetics (PBPK) modeling on Global Health
  • The role of pharmacometrics in understanding Variability in Clinical Trials
  • Extended Model-Informed Drug Development: Beyond Clinical Trials and Regulatory Approval

Best practices for implementing technologies that streamline drug submission and approval processes

  • Diversity in Clinical Trial Enrollment and meeting requirements of the FDA Diversity Action Plan
  • Using real-world data to inform clinical patient management and treatment guidelines for COVID-19
  • Unlocking the Synergies of Generative AI in Regulatory Writing
  • Preventing chaos: The Critical Role of the Submission Lead

To learn more about Certara’s publications, please visit: www.certara.com/resources/publication

About Certara
Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com.

Certara Contact:
Sheila Rocchio
sheila.rocchio@certara.com

Media Contact:
Alyssa Horowitz
certara@pancomm.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.